XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1

REVENUE (Tables)

3 Months Ended

Mar. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Total Revenue by Type and by U.S versus Rest of World

The following table presents detail regarding the composition of the Company’s total revenue by product type and by geographical region, either U.S. or rest of world (“RoW”):

			Three months ended March 31,
			2023																					2022
(in millions)			U.S.						RoW						Total									U.S.						RoW						Total
Testing revenues:
Hereditary Cancer			$	64.0					$	11.7					$	75.7								$	60.7					$	10.2					$	70.9
Tumor Profiling			28.8						8.5						37.3									19.7						12.8						32.5
Prenatal			36.0						0.2						36.2									31.7						0.2						31.9
Pharmacogenomics			32.0						—						32.0									29.3						—						29.3
Other			—						—						—									0.3						—						0.3
Total revenue			$	160.8					$	20.4					$	181.2								$	141.7					$	23.2					$	164.9

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration